Videos

Lyudmila Bazhenova, MD, reviews the treatment options for BRAF mutations in lung cancer, a topic she presented at the 2022 Great Debates & Updates in Lung Cancer meeting in New York.

Edward Garon, MD, discusses the treatment of patients with non-small cell lung cancer and a PD-L1 expression of ≥50%, a topic he debated at the 2022 Great Debates and Updates in Lung Cancer meeting in New York.

Jia Ruan, MD, highlights recent advancements in the treatment of patients with T-Cell non-Hodgkin lymphoma, presenting updated information on novel agents and ongoing clinical trials in this space.

Oliver Zivanovic, MD, defends HIPEC as standard of care treatment for patients with ovarian cancer, a topic he presented at the 2022 Great Debates and Updates in Women’s Oncology virtual meeting.

Lyudmila Bazhenova, MD, University of California, San Diego, California, discusses the management and treatment of patients with HER2-mutated non-small cell lung cancer, a topic she presented at the 2022 Great Debates and Updates in Lung...

Julie Heimbach, MD, discusses a benchmark study that investigated outcomes of patients who received neoadjuvant chemoradiotherapy followed by liver transplantation for perihilar cholangiocarcinoma.

Julie Vose, MD, provides insight into the latest approaches to initial therapy for patients with aggressive diffuse large B-cell lymphoma at the 2022 Lymphoma, Leukemia & Myeloma Congress in New York.